CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Intracellular Micronutrient Analysis - Medical Coverage Policy

Policy governing coverage of intracellular micronutrient testing (laboratory-developed panels measuring intracellular vitamin/mineral levels) for Blue Cross Blue Shield - Rhode Island members.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyIntracellular Micronutrient Analysis - Medical Coverage Policy

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateJun 1, 2017

Next Review DateN/A

Key ActionDo not bill or expect coverage for intracellular micronutrient panel testing — it is considered not medically necessary and claims may be denied.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

2017-06-01effective date

2023-01-18policy last updated

2reference commercial laboratories offering the test

Noneidentified studies evaluating direct health impact

Not medically necessarycoverage stance

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria for Intracellular Micronutrient Testing

Not Medically Necessary

Not covered — evidence insufficient

Not medically necessary - Commercial Products: Intracellular micronutrient panel testing is considered not medically necessary as the evidence is insufficient to determine the effects of the technology on health outcomes.

No randomized controlled trials or comparative studies identified; no analytic validity, clinical validity, or clinical utility demonstrated compared with standard serum testing.

Intracellular micronutrient panel testing is not covered for commercial products. This testing is considered not medically necessary because the published evidence is inadequate to demonstrate meaningful effects on health outcomes.

The rationale for noncoverage is that available studies are limited to observational data and correlations; no studies demonstrate analytic validity, clinical validity, or clinical utility compared with standard serum testing. No randomized controlled trials or comparative studies were identified that show intracellular testing leads to improved patient outcomes, and there are insufficient data to establish a chain of evidence that results would change management in a way that benefits patients.

Covered Indications

No covered indications are specified in this policy.

Covered Indications - None: The policy does not list any clinical indications for which intracellular micronutrient panel testing is covered; potential uses (screening for deficiencies or aiding diagnosis in nonspecific symptoms) are mentioned in background but are not supported as covered indications.

Refer to policy statement: testing is not covered because evidence is insufficient to determine effects on health outcomes.

Coding and Billing

Coding guidanceCPT

unlisted code

No specific CPT code exists; claims should be filed with an unlisted code. Do not report with specific CPT codes for individual panel elements.

CPT availability and billing notes

Specific CPT availabilityNo specific CPT code exists for intracellular micronutrient panel testing; claims should be filed with an unlisted CPT code.

Reporting guidanceDo not report the panel by billing the specific CPT codes for individual elements of the panel; use an unlisted code instead.

ApplicabilityApplies to Medicare Advantage Plans and Commercial Products per policy coding guidance.

Provider Actions, Billing and Authorization

Prior Authorization

Prior authorization: Not applicable

Prior authorization is not required for intracellular micronutrient panel testing.

Note

Benefits may vary by contract

Benefits for intracellular micronutrient testing may vary by group and contract; providers should consult the member's benefit plan for coverage details.

Billing Rule

Use unlisted CPT code; do not report individual CPTs

Background and Rationale

Intracellular micronutrient analysis measures intracellular levels of vitamins, minerals, amino acids, antioxidants and other metabolites in cell samples (for example, lymphocytes or buccal epithelial cells). Commercial reference laboratories offer panels that assess these intracellular micronutrient concentrations, but classical nutritional deficiency diseases are uncommon in the U.S., and standard serum tests remain the typical method for confirming deficiencies.

Definitions

Intracellular micronutrient testing — definition and alternate names

Primary definitionIntracellular micronutrient testing: laboratory tests that measure intracellular levels of micronutrients in cell samples (e.g., lymphocytes from blood or epithelial buccal swabs).

Alternate namesAlso called intracellular micronutrient analysis, micronutrient testing, or functional intracellular analysis.

Brief descriptionThese panels evaluate intracellular vitamins, minerals, antioxidants, amino acids, fatty acids, and metabolites; some assays use lymphocytes (blood) and others use epithelial buccal swabs.

Rationale for testing claimProponents state intracellular levels may reflect more stable micronutrient status over time and be less influenced by recent intake than serum levels, though the relation between serum and intracellular levels is complex.

Frequency Limits

Intracellular micronutrient panel — frequency and interval

Frequency/IntervalNo specific frequency limits or testing interval are specified in the policy for intracellular micronutrient panels.

Benefits variation noteBenefits may vary between groups and contracts; refer to the appropriate section of the benefit for any plan-specific limits.

Billing implicationBecause there is no specific CPT code, claims are filed with an unlisted code which may affect adjudication and frequency review at claim level.

Ordering and Availability

Documentation Required

Ordering: Reference labs (CLIA) — no special authorization

Testing is available through two reference laboratories under CLIA; no special prior authorization or other ordering requirements are specified.

Available through SpectraCell Laboratories and IntraCellular Diagnostics under CLIA.
Laboratory-developed tests must be CLIA-licensed for high-complexity testing.

Not Covered

Intracellular micronutrient panel testing is not covered and is considered not medically necessary. Claims for this testing may be denied on that basis.